Zoetis Australia
Zoetis Australia Pty Limited is the Australian subsidiary of Zoetis Inc., selling vaccines, parasiticides, biologics, diagnostics, and genetics products across livestock and companion animal segments via a sales-led model. It serves veterinarians, livestock producers, and pet owners nationwide.
- Company typePrivate
- Founded1950
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Zoetis Australia does
Zoetis Australia Pty Limited is the Australian operating subsidiary of Zoetis Inc. (NYSE: ZTS), the world's leading animal health company and a Fortune 500 enterprise headquartered globally with $9.3 billion in 2024 revenue across 100+ countries. The Australian entity was incorporated as a private subsidiary following Zoetis's 2013 spin-off from Pfizer, with a parallel Zoetis Australia Research & Manufacturing entity supporting local operations. From offices in Sydney and a nationwide field sales network, the company sells a comprehensive portfolio of vaccines, parasiticides, pharmaceuticals, biologics, diagnostics, and genetics across ten species segments: beef cattle, dairy cattle, sheep, pigs, poultry, goats, canine, feline, and equine.
The product portfolio spans mature franchises such as ULTRAVAC 7IN1 (clostridial vaccine), DECTOMAX (parasiticide), and PESTIGARD (BVD vaccine), as well as differentiated biologics including Cytopoint (canine anti-IL-31 monoclonal antibody), Solensia (feline anti-NGF monoclonal), and Pro-Stride APS (equine regenerative medicine). Digital platforms — Zoetis Direct e-commerce, Livestock Solutions portal (15,000+ farmers), FarmPlanner vaccination scheduler, Zoetis Academy continuing education, Health4Horses Hendra registry, and Vetscan point-of-care diagnostics — layer ecosystem engagement on top of the product offering.
Zoetis Australia generates revenue primarily through one-time product sales to veterinarians, livestock producers, and pet owners, distributed via a sales-led model combining Professional Sales Representatives calling on clinics and farms, the Zoetis Direct online storefront, and traditional veterinary and agricultural resellers. Customer service, technical support, accounts, genetics, and Vetscan support operate through dedicated 1800 telephone lines during Australian business hours. Pricing is not publicly disclosed; veterinary and producer accounts access consistent pricing via Zoetis Direct. Beyond the core commercial model, the company maintains a flagship 11-year Beyond Blue rural mental health partnership (since 2016) and secondary alliances with Greyhound Rescue, Integra Service Dogs, and Seeing Eye Dogs Vision Australia.
Zoetis Australia firmographics
Firmographics- Name
- Zoetis Australia
- Legal name
- Zoetis Australia Pty Limited
- Website
- https://www2.zoetis.com.au
- Company type
- Private
- Founded year
- 1950
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Zoetis Australia Pty Limited is the Australian subsidiary of Zoetis Inc., selling vaccines, parasiticides, biologics, diagnostics, and genetics products across livestock and companion animal segments via a sales-led model. It serves veterinarians, livestock producers, and pet owners nationwide.
- Ownership category
- akta.pro rank
Zoetis Australia industry classification
Industry- Product category
- Animal Health Pharmaceuticals
- NAICS
- Veterinary Services (54194), Veterinary Services (541940)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Agricultural Prod-Livestock & Animal Specialties (200)
- akta.pro primary industry
- Veterinary Vaccines (Biologics) (HLAMAEAL)
- akta.pro secondary industries
- Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Poultry Vaccines (HLAMAKAC), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Antimicrobials & Anti-infectives (HLAMAEAE)
Keywords
Where Zoetis Australia is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Zoetis Australia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Animal Health Products: Zoetis Australia generates revenue primarily through the sale of animal health products including vaccines, parasiticides, antibiotics, diagnostics, and genetics solutions to veterinarians, livestock farmers, and pet owners across Australia.
- Zoetis Direct E-commerce: Direct-to-consumer e-commerce platform allowing veterinarians and pet owners to purchase products directly from Zoetis at consistent low prices.
- Professional Services and Training: Zoetis Academy provides veterinary education and training programs, though primary revenue remains from product sales rather than service fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Zoetis Direct - Direct purchase from Zoetis |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Zoetis Australia product offering
Product offeringCore offering
Zoetis Australia develops, manufactures, and sells animal health products for livestock and companion animals in Australia. The core offering covers vaccines (modified-live, inactivated, gene-modified), parasiticides, antibiotics, monoclonal antibody biologics, in ovo poultry biodevices, point-of-care diagnostics (Vetscan), and genetic evaluation services. Products are sold to veterinarians, livestock producers, and pet owners across beef, dairy, sheep, pig, poultry, canine, feline, equine, and goat segments.
Product overview
Zoetis Australia operates as the animal health division of a Fortune 500 company, offering a comprehensive portfolio of pharmaceutical products, vaccines, parasiticides, and diagnostics across multiple species segments. The product ecosystem spans livestock (beef cattle, dairy cattle, sheep, goats, pigs, poultry) and companion animals (canine, feline, equine). Key product categories include: vaccines (ULTRAVAC 7IN1, PESTIGARD, EQUIVAC, GLANVAC, FEVAC, Fostera Gold PCV), parasiticides (DECTOMAX, SIMPARICA, REVOLUTION, STARTECT), pharmaceuticals (APOQUEL, CERENIA, PALLADIA, CLAVULOX), biologics (CYTOPOINT, SOLENSIA, PRO-STRIDE APS), diagnostics (Vetscan platform including hematology and chemistry analyzers), and digital platforms (Livestock Solutions management portal, FarmPlanner scheduling tool, Zoetis Academy education platform, Health4Horses registry, Zoetis Direct e-commerce). Products are distributed through veterinarians, veterinary wholesalers, and direct via Zoetis Direct platform.
Differentiator
Problem solved
Functional benefit
Brands
- Livestock Solutions: A central point for livestock producers to access valuable tools and information for management of their operations, with specific sections for dairy, beef cattle and sheep.
- Zoetis Academy
- FarmPlanner
- Health4Horses
- Zoetis Direct
Products and services
- Zoetis Vaccine Portfolio
Quantifiable outcome
- Livestock Solutions platform used by 15,000+ farmers for daily weather reports, daily indicators, and FarmPlanner access
- +2 more outcomes
Companies that use Zoetis Australia
Customer profileNamed customers1 record
Segments10 records
Ideal customer profiles7 records
Zoetis Australia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Zoetis Australia partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered flagship and minor.
- Beyond BlueflagshipZoetis partnered with Beyond Blue in 2016 (partnership celebrating 11th year in 2026) to support mental health in rural and regional Australian communities. Zoetis has raised $900,000 through donating $5 from each sale of livestock, pig, and poultry vaccines and drenches. More than 18,500 Australians have accessed mental health support through this partnership, which contributed $1 million over the past decade. The 2026 campaign aims to raise a further $100,000.
- Greyhound RescueminorGreyhound Rescue ethically rescues, lovingly rehabilitates, and safely rehomes greyhounds giving them a voice through advocacy and education. Established in 2009, it is Australia's largest independent greyhound rehoming organisation, finding homes for hounds no longer wanted by the racing industry so they can live as cherished family pets.
- Integra (Service Dogs Australia)minorIntegra is a national charity founded in 2016 by Veterans, Australia's leading supplier of psychiatric assistance dogs. Specialises in training and placement of certified Service Dogs and currently supports more than 110 teams of service dogs with Veterans and First Responders living with PTSD.
- Seeing Eye Dogs (Vision Australia)minorSeeing Eye Dogs, a division of Vision Australia established in 1960, enhances mobility and independence of people who are blind or vision impaired throughout Australia by providing Seeing Eye Dogs, mobility training and rehabilitation services. Training is entirely one-on-one, user-driven approach.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Zoetis Australia competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights6 records
Customer concentration
Zoetis Australia social profiles
Digital presenceZoetis Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zoetis Australia leadership team
Management profileNumber of profiles
Zoetis Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zoetis Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zoetis Australia
What does Zoetis Australia do?
Zoetis Australia develops, manufactures, and sells animal health products for livestock and companion animals in Australia. The core offering covers vaccines (modified-live, inactivated, gene-modified), parasiticides, antibiotics, monoclonal antibody biologics, in ovo poultry biodevices, point-of-care diagnostics (Vetscan), and genetic evaluation services. Products are sold to veterinarians, livestock producers, and pet owners across beef, dairy, sheep, pig, poultry, canine, feline, equine, and goat segments.
Is Zoetis Australia a public or private company?
Zoetis Australia is a private company. It is classified as corporate owned and is currently operating.
When was Zoetis Australia founded?
Zoetis Australia was founded in 1950. It employs 11 to 50 people.
Where is Zoetis Australia based?
Zoetis Australia is headquartered in Sydney, Australia, in the Oceania region.
How does Zoetis Australia make money?
Three revenue lines are on record. Animal Health Products are the primary driver. The others are zoetis Direct E-commerce and professional Services and Training.
Does Zoetis Australia have an API?
No public API is recorded for Zoetis Australia.
What industry is Zoetis Australia in?
Zoetis Australia's product category is Animal Health Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats). Its NAICS code is 54194 and its SIC code is 2836.